Cargando…
Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo
BACKGROUND: Bifidobacteria and lactobacilli are among the early and important colonizers of the gastrointestinal tract and are generally considered to be part of a normal, healthy microbiota. It is believed that specific strains within the microbiota can influence host immune-reactivity and may play...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016395/ https://www.ncbi.nlm.nih.gov/pubmed/21176205 http://dx.doi.org/10.1186/1471-2172-11-63 |
_version_ | 1782195739544256512 |
---|---|
author | O'Mahony, David Murphy, Sharon Boileau, Thomas Park, JeanSoon O'Brien, Frances Groeger, David Konieczna, Patrycja Ziegler, Mario Scully, Paul Shanahan, Fergus Kiely, Barry O'Mahony, Liam |
author_facet | O'Mahony, David Murphy, Sharon Boileau, Thomas Park, JeanSoon O'Brien, Frances Groeger, David Konieczna, Patrycja Ziegler, Mario Scully, Paul Shanahan, Fergus Kiely, Barry O'Mahony, Liam |
author_sort | O'Mahony, David |
collection | PubMed |
description | BACKGROUND: Bifidobacteria and lactobacilli are among the early and important colonizers of the gastrointestinal tract and are generally considered to be part of a normal, healthy microbiota. It is believed that specific strains within the microbiota can influence host immune-reactivity and may play a role in protection from infection and aberrant inflammatory activity. One such strain, Bifidobacterium animalis AHC7, has been previously shown to protect against Salmonella typhimurium infection in mice and helps resolve acute idiopathic diarrhea in dogs. The aim of this study was to investigate the potential molecular and cellular mechanisms underpinning the Bifidobacterium animalis AHC7 protective effect. RESULTS: Following 4 hours of infection with Salmonella typhimurium, NF-κB activation was significantly elevated in vivo in placebo and Enterococcus faecium-fed animals while Bifidobacterium animalis AHC7 consumption significantly attenuated the NF-κB response. In vitro anti-CD3/CD28 stimulated Peyer's patch cells secreted significantly less TNF-α and IFN-γ following Bifidobacterium animalis AHC7 consumption. Stimulated cells released more IL-12p70 but this difference did not reach statistical significance. No alteration in mucosal IL-6, IL-10 or MCP-1 levels were observed. No statistically significant change in the cytokine profile of mesenteric lymph node cells was noted. In vitro, Bifidobacterium animalis AHC7 was bound by dendritic cells and induced secretion of both IL-10 and IL-12p70. In addition, co-culture of CD4+ T cells with Bifidobacterium animalis AHC7-stimulated dendritic cells resulted in a significant increase in CD25+Foxp3+ T cell numbers. CONCLUSION: Bifidobacterium animalis AHC7 exerts an anti-inflammatory effect via the attenuation of pro-inflammatory transcription factor activation in response to an infectious insult associated with modulation of pro-inflammatory cytokine production within the mucosa. The cellular mechanism underpinning Bifidobacterium animalis AHC7 mediated attenuation of NF-κB activation may include recognition of the bacterium by dendritic cells and induction of CD25+Foxp3+ T cells. |
format | Text |
id | pubmed-3016395 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30163952011-01-06 Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo O'Mahony, David Murphy, Sharon Boileau, Thomas Park, JeanSoon O'Brien, Frances Groeger, David Konieczna, Patrycja Ziegler, Mario Scully, Paul Shanahan, Fergus Kiely, Barry O'Mahony, Liam BMC Immunol Research Article BACKGROUND: Bifidobacteria and lactobacilli are among the early and important colonizers of the gastrointestinal tract and are generally considered to be part of a normal, healthy microbiota. It is believed that specific strains within the microbiota can influence host immune-reactivity and may play a role in protection from infection and aberrant inflammatory activity. One such strain, Bifidobacterium animalis AHC7, has been previously shown to protect against Salmonella typhimurium infection in mice and helps resolve acute idiopathic diarrhea in dogs. The aim of this study was to investigate the potential molecular and cellular mechanisms underpinning the Bifidobacterium animalis AHC7 protective effect. RESULTS: Following 4 hours of infection with Salmonella typhimurium, NF-κB activation was significantly elevated in vivo in placebo and Enterococcus faecium-fed animals while Bifidobacterium animalis AHC7 consumption significantly attenuated the NF-κB response. In vitro anti-CD3/CD28 stimulated Peyer's patch cells secreted significantly less TNF-α and IFN-γ following Bifidobacterium animalis AHC7 consumption. Stimulated cells released more IL-12p70 but this difference did not reach statistical significance. No alteration in mucosal IL-6, IL-10 or MCP-1 levels were observed. No statistically significant change in the cytokine profile of mesenteric lymph node cells was noted. In vitro, Bifidobacterium animalis AHC7 was bound by dendritic cells and induced secretion of both IL-10 and IL-12p70. In addition, co-culture of CD4+ T cells with Bifidobacterium animalis AHC7-stimulated dendritic cells resulted in a significant increase in CD25+Foxp3+ T cell numbers. CONCLUSION: Bifidobacterium animalis AHC7 exerts an anti-inflammatory effect via the attenuation of pro-inflammatory transcription factor activation in response to an infectious insult associated with modulation of pro-inflammatory cytokine production within the mucosa. The cellular mechanism underpinning Bifidobacterium animalis AHC7 mediated attenuation of NF-κB activation may include recognition of the bacterium by dendritic cells and induction of CD25+Foxp3+ T cells. BioMed Central 2010-12-22 /pmc/articles/PMC3016395/ /pubmed/21176205 http://dx.doi.org/10.1186/1471-2172-11-63 Text en Copyright ©2010 O'Mahony et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article O'Mahony, David Murphy, Sharon Boileau, Thomas Park, JeanSoon O'Brien, Frances Groeger, David Konieczna, Patrycja Ziegler, Mario Scully, Paul Shanahan, Fergus Kiely, Barry O'Mahony, Liam Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo |
title | Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo |
title_full | Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo |
title_fullStr | Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo |
title_full_unstemmed | Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo |
title_short | Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo |
title_sort | bifidobacterium animalis ahc7 protects against pathogen-induced nf-κb activation in vivo |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016395/ https://www.ncbi.nlm.nih.gov/pubmed/21176205 http://dx.doi.org/10.1186/1471-2172-11-63 |
work_keys_str_mv | AT omahonydavid bifidobacteriumanimalisahc7protectsagainstpathogeninducednfkbactivationinvivo AT murphysharon bifidobacteriumanimalisahc7protectsagainstpathogeninducednfkbactivationinvivo AT boileauthomas bifidobacteriumanimalisahc7protectsagainstpathogeninducednfkbactivationinvivo AT parkjeansoon bifidobacteriumanimalisahc7protectsagainstpathogeninducednfkbactivationinvivo AT obrienfrances bifidobacteriumanimalisahc7protectsagainstpathogeninducednfkbactivationinvivo AT groegerdavid bifidobacteriumanimalisahc7protectsagainstpathogeninducednfkbactivationinvivo AT koniecznapatrycja bifidobacteriumanimalisahc7protectsagainstpathogeninducednfkbactivationinvivo AT zieglermario bifidobacteriumanimalisahc7protectsagainstpathogeninducednfkbactivationinvivo AT scullypaul bifidobacteriumanimalisahc7protectsagainstpathogeninducednfkbactivationinvivo AT shanahanfergus bifidobacteriumanimalisahc7protectsagainstpathogeninducednfkbactivationinvivo AT kielybarry bifidobacteriumanimalisahc7protectsagainstpathogeninducednfkbactivationinvivo AT omahonyliam bifidobacteriumanimalisahc7protectsagainstpathogeninducednfkbactivationinvivo |